Trabeculectomy With MMC Versus Ahmed Glaucoma Implant for Treatment of Pediatric Aphakic Glaucoma

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00371072

Enrollment

Unknown

Registered

2006-09-01

Start date

2004-03-31

Completion date

2005-11-30

Last updated

2006-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Aphakic Glaucoma

Keywords

Aphakic Glaucoma, trabeculectomy with mitomycin- C, Ahmed glaucoma implant

Brief summary

In this randomized clinical trial we compare trabeculectomy with mitomycin-C (T+MMC) and Ahmed glaucoma implant (AGI) in treatment of aphakic glaucoma in children under 16 years of age.Complete and qualified success were defined as 5≤IOP≤21mmHg without and with medication respectively and we came to this point that; T+MMC and AGI are comparable in terms of success rate and complications in pediatric aphakic glaucoma.

Interventions

PROCEDUREtrabeculectomy with mitomycin-C

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE

Eligibility

Sex/Gender

ALL

Age

0 Years to 16 Years

Healthy volunteers

Inclusion criteria

* congenital cataract * history of cataract surgery * under 16 years old * Ocular pressure more than 21 mmHg

Exclusion criteria

* interruption of the follow up before 6 month * Anterior segment dysgenesis

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026